재택 진단 시장 : 전략과 동향 - 용도별, 채널별, 기술별, 국가별 예측 - 시장 분석 및 경영자용 가이드 포함, 인공지능(AI)의 영향(2026-2030년)

Report Overview:

Point-of-Care (POC) Home Diagnostics represent one of the fastest growing segments of the in vitro diagnostics (IVD) industry, reflecting a broader shift toward decentralized healthcare delivery and increased patient engagement in health management. Home diagnostic tests allow individuals to perform medical testing outside traditional clinical settings, providing rapid results that support disease detection, monitoring, and preventive health management. These tests enable patients to access health information more conveniently while reducing dependence on laboratory visits or physician appointments for certain types of testing.

The global POC home diagnostics market is estimated to be USD 4.49 billion in 2025 and is expected to grow at compound annual growth rates of 9.9% to reach USD 7.2 Billion in 2030. Growth is supported by increasing demand for convenient healthcare solutions, expansion of telehealth services, technological advances in biosensor design, and increasing consumer interest in proactive health monitoring.

Home diagnostic technologies play an important role in improving healthcare accessibility, particularly for patients requiring frequent monitoring of chronic conditions or individuals seeking rapid screening for infectious diseases. Increased consumer familiarity with home testing technologies, particularly following widespread use of COVID-19 self-tests, has contributed to growing acceptance of decentralized diagnostic solutions.

Scope of Home Diagnostic Testing

The POC home diagnostics market includes a wide range of test categories addressing both medical and wellness applications.

Infectious disease testing represents a significant segment, including rapid tests for respiratory infections, influenza, COVID-19, and other communicable diseases. Home testing enables early identification of infectious conditions and supports public health efforts to reduce disease transmission.

Chronic disease monitoring tests represent another important segment. Blood glucose monitoring systems are widely used by patients with diabetes to manage blood sugar levels. Additional chronic disease monitoring applications include cholesterol testing, kidney function monitoring, and coagulation monitoring.

Reproductive health testing represents a well-established segment of the home diagnostics market. Pregnancy tests and ovulation prediction kits are widely used consumer diagnostic products. Fertility monitoring systems increasingly incorporate digital tracking capabilities.

Cardiometabolic testing applications include lipid profile monitoring and HbA1c testing for diabetes management.

Genetic and wellness testing services are expanding as consumers seek personalized health insights related to nutrition, fitness, aging, and inherited health risks.

Drug testing and toxicology screening applications are also available for home use in certain markets.

Advances in biosensor technologies are enabling development of compact diagnostic devices capable of analyzing small sample volumes with high sensitivity.

Technology Platforms

Home diagnostic devices typically use simplified versions of technologies originally developed for clinical laboratories. Lateral flow assays are widely used for rapid infectious disease testing due to their ease of use and rapid result generation.

Electrochemical biosensors are commonly used in glucose monitoring systems and other metabolic tests.

Microfluidics technologies enable miniaturization of laboratory processes into portable diagnostic devices.

Digital connectivity features allow home diagnostic devices to transmit results to smartphone applications or cloud-based health platforms.

Integration with mobile applications enables users to track health trends over time.

Advances in sensor technology are improving sensitivity and reliability of home diagnostic devices.

Automation of test procedures reduces reliance on user technique.

Connectivity features enable integration of home testing data with telehealth platforms.

Market Drivers

Several factors are driving growth in the point-of-care home diagnostics market.

Increasing prevalence of chronic diseases such as diabetes and cardiovascular disease is creating demand for frequent health monitoring.

Expansion of telehealth services is increasing integration of home diagnostics into remote patient care pathways.

Consumer interest in personalized health insights is increasing demand for wellness testing services.

Healthcare systems are seeking cost-effective approaches to reduce burden on clinical facilities.

Technological advances in biosensor miniaturization are enabling development of user-friendly testing devices.

Increased awareness of infectious disease transmission is supporting demand for rapid home testing solutions.

Aging populations may benefit from convenient home-based diagnostic testing.

Digital health platforms are improving accessibility of health data.

Remote patient monitoring programs are increasing adoption of home testing devices.

Market Segmentation

North America represents a major regional market due to high consumer adoption of digital health technologies.

Europe represents a significant market supported by healthcare innovation initiatives.

Asia-Pacific markets are expanding due to increasing healthcare access and smartphone adoption.

Emerging markets may benefit from decentralized diagnostic solutions due to limited access to healthcare infrastructure.

Competitive Landscape

The point-of-care home diagnostics market includes diagnostic device manufacturers, consumer health companies, digital health platform developers, and biotechnology companies.

Competition is influenced by product accuracy, ease of use, brand recognition, and digital connectivity capabilities.

Consumer trust represents an important factor influencing product adoption.

Companies are increasingly developing integrated digital health ecosystems combining diagnostic testing with mobile applications.

Strategic partnerships between diagnostic companies and telehealth providers are becoming more common.

Product differentiation may be achieved through user-friendly design and digital integration features.

Direct-to-consumer marketing strategies play an important role in product adoption.

Recurring revenue models may include subscription services for test supplies.

Future Outlook

The POC home diagnostics market is expected to continue expanding as healthcare systems emphasize convenience, accessibility, and patient engagement.

Advances in biosensor technologies may enable development of more sophisticated home testing solutions.

Integration of home diagnostic data with telehealth platforms may improve care coordination.

Artificial intelligence tools may improve interpretation of home test results.

Expansion of remote patient monitoring programs may increase adoption of home diagnostic devices.

Consumer interest in preventive health management is expected to support long-term market growth.

Overall, point-of-care home diagnostics represent an important component of decentralized healthcare delivery. Continued advances in digital health technologies, biosensors, and connectivity platforms are expected to support sustained market expansion.

Table of Contents

1 Market Guides

• 1.1 Situation Analysis
  • 1.1.1 Shift Toward Decentralized Healthcare Delivery
  • 1.1.2 Product Scope and Technology Platforms
  • 1.1.3 Accuracy, Reliability, and Clinical Validation
  • 1.1.4 Regulatory and Compliance Considerations
  • 1.1.5 Consumer Engagement and Usability Challenges
  • 1.1.6 Reimbursement and Economic Considerations
  • 1.1.7 Competitive Landscape and Market Structure
  • 1.1.8 Data Integration and Healthcare Connectivity
  • 1.1.9 Geographic Market Dynamics
  • 1.1.10 Outlook and Strategic Implications
• 1.2 Guide for Executives and Marketing Staff
• 1.3 Guide for Investment Analysts and Management Consultants
• 1.4 Impact of Aritificial Intelligence

2 Introduction and Market Definition

• 2.1 What are Home Diagnostics?
• 2.2 Home Testing - the quiet revolution in diagnostics
• 2.3 Self vs. Send vs. In House - Who knew?
  • 2.3.1 Self
  • 2.3.2 Send
  • 2.3.3 In-House
• 2.4 Market Definition
  • 2.4.1 Retail vs. Wholesale
• 2.5 Application Segments
  • 2.5.1 Channel Segments
  • 2.5.2 Technology Segments
  • 2.5.3 Currency
  • 2.5.4 Years
• 2.6 Methodology
  • 2.6.1 Methodology
  • 2.6.2 Sources
  • 2.6.3 Authors
• 2.7 Perspective: Healthcare and the IVD Industry
  • 2.7.1 Global Healthcare Spending
  • 2.7.2 Spending on Diagnostics
  • 2.7.3 Important Role of Insurance for Diagnostics

3 Industry Overview

• 3.1 Players in a Dynamic Market
  • 3.1.1 Academic Research Lab
  • 3.1.2 Diagnostic Test Developer
  • 3.1.3 Instrumentation Supplier
  • 3.1.4 Chemical/Reagent Supplier
  • 3.1.5 Pathology Supplier
  • 3.1.6 Independent Clinical Laboratory
  • 3.1.7 Public National/regional Laboratory
  • 3.1.8 Hospital Laboratory
  • 3.1.9 Physicians Office Lab (POLS)
  • 3.1.10 Audit Body
  • 3.1.11 Certification Body
• 3.2 Diagnostic Market Segments
  • 3.2.1 Traditional Market Segmentation
  • 3.2.2 Laboratory Focus and Segmentation
  • 3.2.3 Segmenting the Home Diagnostics Market
• 3.3 Industry Structure
  • 3.3.1 Hospital Testing Share
  • 3.3.2 Economies of Scale
  • 3.3.3 Hospital vs. Central Lab
  • 3.3.4 Physician Office Lab's
    • 3.3.4.1 The Problem with POLS
  • 3.3.5 Physician's and Home Diagnostics
  • 3.3.6 Pharmacies and Home Diagnostics
    • 3.3.6.1 The Diagnostic Plight of Pharmacies - Trying to do good
    • 3.3.6.2 The Theranos Legacy

4 Market Trends

• 4.1 Factors Driving Growth
  • 4.1.1 Privacy and Anonymity
  • 4.1.2 The Internet Effect
  • 4.1.3 Rapid Result
  • 4.1.4 The Wellness Movement
  • 4.1.5 The COVID-19 Impact
• 4.2 Factors Limiting Growth
  • 4.2.1 Trust Factor
  • 4.2.2 Infectious Disease is Declining But....
  • 4.2.3 Wellness Hurts
  • 4.2.4 Economic Growth improves Living Standards
• 4.3 Diagnostic Technology Development
  • 4.3.1 The Multiplex Paradigm Shift
  • 4.3.2 NAT vs. Lateral Flow
  • 4.3.3 The Unusual Role of GPS
  • 4.3.4 Self and Send Competition
  • 4.3.5 The Relationship to DTC Genetic
  • 4.3.6 The Relationship to TeleHealth
  • 4.3.7 Sample Collection - Who Knew?

5 Home Diagnostics Recent Developments

• 5.1 Recent Developments - Importance and How to Use This Section
  • 5.1.1 Importance of These Developments
  • 5.1.2 How to Use This Section
• 5.2 Health Canada Approves NanoSpeed Diagnostics POC Vitamin D Test
• 5.3 Visby Medical At-Home MDx STI Test Approved
• 5.4 Cubit Diagnostics Gets Funding for COVID/Flu Test on Multimodal Platform
• 5.5 OraSure Technologies Acquires Sherlock Biosciences
• 5.6 Atomo Diagnostics Awarded Grant for Syphilis Test
• 5.7 Shuwen Biotech Gets Approval for POC Preeclampsia Test
• 5.8 Watmind Get Two EUAs
• 5.9 Capitainer, Life Genomics Partner on Self-Sampling Diagnostics
• 5.10 MyGeneticScreen Home Test Launched
• 5.11 Demand for OTC Self-Tests Tempered by Lack of Reimbursement
• 5.12 DiaCarta OTC Fecal Occult Blood Test Receives FDA Approval
• 5.13 LetsGetChecked Nabs FDA Authorization for Chlamydia, Gonorrhea Test
• 5.14 DiagMetrics Developing Breath Assays
• 5.15 Co-Diagnostics Awarded $2.3M for TB, HPV Tests
• 5.16 POC Developers Nuclein and Minute Molecular Dx Merge
• 5.17 ReadyGo Dx to Make MDx Testing a 'Snap'
• 5.18 Altratech Enters POC Testing Space by Supplanting PCR
• 5.19 Sherlock Biosciences to Acquire Sense Biodetection
• 5.20 Scripps Research, Cue Health to Offer Home Based Test-to-Treat Program
• 5.21 KSL Pulse Scientific to Distribute Home Molecular Test in Canada
• 5.22 Juno Diagnostics Offers NIPT With At-Home Sample Collection
• 5.23 Sherlock Biosciences Adds to Diagnostic Toolkit
• 5.24 Morgan Health Invests in LetsGetChecked
• 5.25 Prenetics ColoClear by Circle
• 5.26 Detect to Roll Out Next-Gen Molecular Instrument
• 5.27 Diagnostics for the Real World Third-Generation POC Platform
• 5.28 Labcorp Partnering With Getlabs for Home Collection
• 5.29 Salignostics Closes Funding Round
• 5.30 Cue Health Targets DTC Market in 2022
• 5.31 Grip Molecular Developing Home Respiratory Panel
• 5.32 Mainz Biomed Developing Home ColoAlert Assay
• 5.33 MFB Fertility Closes Series A Financing Round
• 5.34 Continued Demand for SARS-CoV-2 Rapid Tests
• 5.35 Rapid Covid-19 Test Results Risk Going Uncounted
• 5.36 FDA Grants EUAs for Direct-to-Consumer Coronavirus Kit
• 5.37 Researchers Develop 15-Minute PCR System
• 5.38 Stanford Developing Low-Cost, At-Home, COVID-19 Saliva Test
• 5.39 Lucira Health Files for $115M IPO
• 5.40 Spectrum Solutions Gets CE Mark for Saliva Collection Devices

6 Profiles of Key Home Diagnostics Companies

• 6.1 1DropDiagnostics
• 6.2 23andME Inc.
• 6.3 Abbott Laboratories
• 6.4 Accel Diagnostics
• 6.5 ADT Biotech
• 6.6 Akonni Biosystems
• 6.7 AlphaBiolabs
• 6.8 Alveo Technologies
• 6.9 Anitoa
• 6.10 Applied BioCode
• 6.11 Atomo Diagnostics
• 6.12 Aureum Diagnostics
• 6.13 Aus Diagnostics
• 6.14 Becton, Dickinson and Company
• 6.15 Binx Health
• 6.16 Biocartis
• 6.17 BioFire Diagnostics (bioMerieux)
• 6.18 bioMerieux Diagnostics
• 6.19 Bio-Rad Laboratories, Inc
• 6.20 Bosch Healthcare Solutions GmbH
• 6.21 Cepheid (Danaher)
• 6.22 Cue Health
• 6.23 Curetis (OpGen)
• 6.24 DBS Systems
• 6.25 Detect
• 6.26 Diagenode Diagnostics (Hologic)
• 6.27 Diasorin S.p.A.
• 6.28 Domus Diagnostics
• 6.29 Ellume
• 6.30 Everywell
• 6.31 Genomadix
• 6.32 Getlabs
• 6.33 Grip Molecular Technologies
• 6.34 Healthy.io
• 6.35 Hologic
• 6.36 Inflammatix
• 6.37 Invetech
• 6.38 Iollo
• 6.39 J&J Innovative Medicine
• 6.40 Karius
• 6.41 Laboratory Corporation of America
• 6.42 Letsgetchecked
• 6.43 LightDeck Diagnostics
• 6.44 Lucira Health (Pfizer)
• 6.45 LumiraDx
• 6.46 Meep
• 6.47 MFB Fertility
• 6.48 myLabBox
• 6.49 NanoDx
• 6.50 Nanomix
• 6.51 OraSure Technologies
• 6.52 Oxford Nanopore Technologies
• 6.53 Panagene
• 6.54 Prenetics
• 6.55 Primerdesign (Novacyt)
• 6.56 Prominex
• 6.57 Proof Diagnostics
• 6.58 Qiagen
• 6.59 QuantuMDx
• 6.60 Quest Diagnostics
• 6.61 QuidelOrtho
• 6.62 Randox Toxicology
• 6.63 Roche Diagnostics
• 6.64 Salignostics
• 6.65 SD Biosensor
• 6.66 Seegene
• 6.67 Siemens Healthineers
• 6.68 T2 Biosystems
• 6.69 TestCard
• 6.70 Thermo Fisher Scientific
• 6.71 Thriva
• 6.72 Visby Medical
• 6.73 XCR Diagnostics
• 6.74 YourBio Health

7 Global Market Size

• 7.1 Home Diagnostics Global Market Size by Country
  • 7.1.1 Home Diagnostics Global Market Size by Country Table
  • 7.1.2 Home Diagnostics Global Market Size by Country Chart
• 7.2 Home Diagnostics Global Market Size by Application
  • 7.2.1 Home Diagnostics Global Market Size by Application Table
  • 7.2.2 Home Diagnostics Global Market Size by Application Share by Year
  • 7.2.3 Home Diagnostics Global Market Size by Application Base vs Final
  • 7.2.4 Home Diagnostics Global Market Size by Application Base Year
  • 7.2.5 Home Diagnostics Global Market Size by Application Final Year
  • 7.2.6 Home Diagnostics Global Market Size by Application Segment Growth
• 7.3 Home Diagnostics Global Market Size by Channel
  • 7.3.1 Home Diagnostics Global Market Size by Channel Table
  • 7.3.2 Home Diagnostics Global Market Size by Channel Share by Year
  • 7.3.3 Home Diagnostics Global Market Size by Channel Base vs Final
  • 7.3.4 Home Diagnostics Global Market Size by Channel Base Year
  • 7.3.5 Home Diagnostics Global Market Size by Channel Final Year
  • 7.3.6 Home Diagnostics Global Market Size by Channel Segment Growth
• 7.4 Home Diagnostics Global Market Size by Technology
  • 7.4.1 Home Diagnostics Global Market Size by Technology Table
  • 7.4.2 Home Diagnostics Global Market Size by Technology Share by Year
  • 7.4.3 Home Diagnostics Global Market Size by Technology Base vs Final
  • 7.4.4 Home Diagnostics Global Market Size by Technology Base Year
  • 7.4.5 Home Diagnostics Global Market Size by Technology Final Year
  • 7.4.6 Home Diagnostics Global Market Size by Technology Segment Growth

8 Global Market by Application

• 8.1 Respiratory Market
  • 8.1.1 Respiratory Market by Country Table
  • 8.1.2 Respiratory Market Chart
• 8.2 STD Market
  • 8.2.1 STD Market by Country Table
  • 8.2.2 STD Market Chart
• 8.3 UTI Market
  • 8.3.1 UTI Market by Country Table
  • 8.3.2 UTI Market Chart
• 8.4 Pregnancy Market
  • 8.4.1 Pregnancy Market by Country Table
  • 8.4.2 Pregnancy Market by Chart
• 8.5 Ovulation Market
  • 8.5.1 Ovulation Market by Country Table
  • 8.5.2 Ovulation Market by Chart
• 8.6 DNA Market
  • 8.6.1 DNA Market by Country Table
  • 8.6.2 DNA Market Chart
• 8.7 Other Market
  • 8.7.1 Other Market by Country Table
  • 8.7.2 Other Market Chart

9 Global Market by Channel

• 9.1 Store Market
  • 9.1.1 Store Market by Country Table
  • 9.1.2 Store Market Chart
• 9.2 Online Market
  • 9.2.1 Online Market by Country Table
  • 9.2.2 Online Market Chart
• 9.3 Other Channel Market
  • 9.3.1 Other Channel by Country Table
  • 9.3.2 Other Channel Market Chart

10 Global Market by Technology

• 10.1 Immunoassay Market
  • 10.1.1 Immunoassay Market by Country Table
  • 10.1.2 Immunoassay Market Chart
• 10.2 Chemistry Market
  • 10.2.1 Chemistry Market by Country Table
  • 10.2.2 Chemistry Market Chart
• 10.3 Nucleic Acid Market
  • 10.3.1 Nucleic Acid Market by Country Table
  • 10.3.2 Nucleic Acid Market Chart
• 10.4 Other Technology Market
  • 10.4.1 Other Technology Market by Country Table
  • 10.4.2 Other Technology Market Chart

11 Appendices

• 11.1 United States Medicare System: Clinical Laboratory Fees Schedule
• 11.2 The Most Used IVD Assays
• 11.3 The Highest Grossing Assays

Table of Tables

• Table 1 Application Segment Definitions
• Table 2 Channel Segment Definitions
• Table 3 Technology Segment Definitions
• Table 4 Market Players by Type
• Table 5 Clinical Laboratory Departments and Segments
• Table 6 Laboratory Management Focus - Different Approaches
• Table 7 Key Segmentation Variables Going Forward
• Table 8 Possible Market Segments of HOME Market
• Table 9 Five Factors Driving Growth
• Table 10 Four Factors Limiting Growth
• Table 11 Self vs. Send TAT
• Table 12 Home Diagnostics Global Market by Country/Region
• Table 13 Home Diagnostics Global Market by Application
• Table 14 Home Diagnostics Global Market by Channel
• Table 15 Home Diagnostics Global Market by Technology
• Table 16 Respiratory by Country
• Table 17 STD market by country
• Table 18 UTI Market by country
• Table 19 Pregnancy Market by country
• Table 20 Ovulation Market by country
• Table 21 DNA Market by country
• Table 22 Other Market by country
• Table 23 Store Market by Country
• Table 24 Online market by country
• Table 25 Other Channel Market by country
• Table 26 Immunoassay by Country
• Table 27 Chemistry Market by country
• Table 28 Nucleic Acid Market by country
• Table 29 Other Technology Market by country
• Table 30 Clinical Lab Fee Schedule
• Table 31 The Most Common Assays
• Table 32 Largest Revenue Assays

Table of Figures

• Figure 1 Standard Test Paradigm
• Figure 2 The New Test Paradigm
• Figure 3 Global Healthcare Spending
• Figure 4 The Lab Test Pie
• Figure 5 The Road to Diagnostics
• Figure 6 Chart Death Rates and Infectious Disease Decline
• Figure 6 The Multiplex Paradigm Shift
• Figure 8 Market Size by Country - Key Countries
• Figure 9 Chart of Global Market by Application by Year
• Figure 10 Application Segment Shares Base vs Final
• Figure 11 Application Share Base Year
• Figure 12 Application Share Final Year
• Figure 13 Application Segment Growth Rates
• Figure 14 Chart of Global Market by Channel by Year
• Figure 15 Channel Segment Shares Base vs Final
• Figure 16 Channel Share Base Year
• Figure 17 Channel Share Final Year
• Figure 18 Channel Segment Growth Rates
• Figure 19 Chart of Global Market by Technology by Year
• Figure 20 Technology Segment Shares Base vs Final
• Figure 21 Technology Share Base Year
• Figure 22 Technology Share Final Year
• Figure 23 Technology Segment Growth Rates
• Figure 24 Chart - Respiratory Market Growth
• Figure 25 Chart - STD Market Growth
• Figure 26 Chart - UTI Market Growth
• Figure 27 Chart - Pregnancy Market Growth
• Figure 28 Chart - Ovulation Market Growth
• Figure 29 Chart - DNA Market Growth
• Figure 30 Chart - Other Market Growth
• Figure 31 Chart - Store Market Growth
• Figure 32 Chart - Online Market Growth
• Figure 33 Chart - Other Channel Market Growth
• Figure 34 Chart - Immunoassay Market Growth
• Figure 35 Chart - Chemistry Market Growth
• Figure 36 Chart - Nucleic Acid Market Growth
• Figure 37 Chart - Other Technology Market Growth